載入...
Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study
Anaplastic thyroid cancer (ATC) is associated with an extremely poor prognosis and is resistant to the majority of chemotherapies. In 2015, lenvatinib was approved for treating ATC in Japan. The present study aimed to evaluate the overall survival (OS) of patients with ATC treated with lenvatinib. A...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256365/ https://ncbi.nlm.nih.gov/pubmed/30546466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9553 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|